A new publication related to setmelanotide research appeared on October 8, 2026. The paper, titled "Human genetic evidence challenges NCOA1 as a monogenic obesity gene," was published in Cell Reports Medicine. The publication presents human genetic evidence concerning the role of NCOA1 as a monogenic obesity gene. No findings, conclusions, or data from the study are detailed here beyond the title and publication venue. Setmelanotide is an approved compound, and genetic research such as this can relate to the broader scientific context in which melanocortin pathway therapies are studied. Readers interested in the specific results of this analysis should consult the original publication directly through the provided source link. For additional background on setmelanotide, including its approved uses and mechanism, readers can consult the compound overview.
New Publication Examines NCOA1 as Monogenic Obesity Gene
See the full setmelanotide overview
Source: https://pubmed.ncbi.nlm.nih.gov/42849447/